nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—pancreas—jejunal cancer	0.267	0.267	CbGeAlD
Lorazepam—UGT2B15—endocrine gland—jejunal cancer	0.189	0.189	CbGeAlD
Lorazepam—TSPO—smooth muscle tissue—jejunal cancer	0.104	0.104	CbGeAlD
Lorazepam—TSPO—pancreas—jejunal cancer	0.0957	0.0957	CbGeAlD
Lorazepam—GABRB3—pancreas—jejunal cancer	0.0869	0.0869	CbGeAlD
Lorazepam—TSPO—lymphoid tissue—jejunal cancer	0.0827	0.0827	CbGeAlD
Lorazepam—TSPO—endocrine gland—jejunal cancer	0.0675	0.0675	CbGeAlD
Lorazepam—GABRB3—endocrine gland—jejunal cancer	0.0613	0.0613	CbGeAlD
Lorazepam—TSPO—lymph node—jejunal cancer	0.0467	0.0467	CbGeAlD
